Edition:
United States

Novozymes A/S (NVZMY.PK)

NVZMY.PK on OTC Markets Group

38.99USD
24 Mar 2017
Change (% chg)

$0.31 (+0.79%)
Prev Close
$38.68
Open
$38.75
Day's High
$39.15
Day's Low
$38.75
Volume
12,758
Avg. Vol
61,932
52-wk High
$49.55
52-wk Low
$31.57

Latest Key Developments (Source: Significant Developments)

Dong Energy to build biogas plant for Novo Nordisk, Novozymes residues
Thursday, 23 Mar 2017 04:18am EDT 

Dong Energy : Says will in cooperation with Bigadan build a large-scale biogas plant . The plant will reuse residues from production facilities of Novozymes and Novo Nordisk in Kalundborg, Denmark . Construction of the new biogas plant will commence in March 2017, and the plant is scheduled for commissioning already in the spring of 2018 .The biogas plant will have a production capacity of 8 million square metres of natural gas per year, corresponding to the consumption of around 5,000 households.  Full Article

Coor Service Management Holding signs agreement with Novozymes in Denmark
Thursday, 23 Mar 2017 04:09am EDT 

Coor Service Management Holding AB : Signs agreement with Novozymes in Denmark . Coor has won five-year agreement with Novozymes .Delivery to Novozymes starts May 1.  Full Article

Novozymes President and CEO buys 27,700 shares at DKK 6,997,574
Thursday, 26 Jan 2017 05:34am EST 

Novozymes A/S :President and CEO Peder Holk Nielsen buys 27,700 shares in Novozymes at 6,997,574 Danish crowns ($1 million).  Full Article

Novozymes EVP Anders Lund sells shares at about DKK 3.6 million
Monday, 23 Jan 2017 08:45am EST 

Novozymes A/S :Executive Vice President Anders Lund has sold 14,477 shares in Novozymes at about 3.6 million Danish crowns ($519,691).  Full Article

Novozymes Q2 EBIT DKK 961 million, below expectations
Wednesday, 10 Aug 2016 02:14am EDT 

Novozymes A/S : Q2 sales 3.43 billion Danish crowns ($512.6 million) (Reuters poll 3.55 billion crowns) . Q2 EBIT 961 million crowns (Reuters poll 981 million crowns) . Outlook for full-year organic sales growth is adjusted to 2-4 pct, down from previously 3-5 pct, to reflect uncertainty in most of the industries in which Novozymes operates. . FY outlook for each of EBIT, EBIT margin, net profit, net investments, free cash flow ROIC is unchanged .FY outlook for sales in Danish crowns is unchanged.  Full Article

Novozymes and DONG Energy sign deal on biological waste sorting
Wednesday, 29 Jun 2016 02:16am EDT 

Novozymes A/S : Novozymes and DONG Energy enter into agreement on biological waste sorting . Novozymes will deliver enzymes for coming renescience plant in Northwich in North West of England . Enzyme supply agreement is a long-term non-exclusive agreement .Novozymes and DONG Energy have also agreed to further develop enzymes for technology together.  Full Article

Novozymes cuts FY 2016 outlook for sales and EBIT growth in Danish crowns
Wednesday, 20 Apr 2016 02:00am EDT 

Novozymes A/S:Outlook for FY 2016 organic sales growth and for net profit growth is unchanged.The outlook for sales and EBIT growth in Danish crowns is adjusted from 3-5 percent to 1-3 percent to account for the lower currency exchange rates.  Full Article

Novozymes A/S changes organizational structure
Monday, 8 Feb 2016 03:00am EST 

Novozymes A/S:Changes in organizational structure and executive leadership team.Says ‍wishes to strengthen its technology and market leadership through establishment of a central research, innovation & supply organization​.Says the costs are expected to be realized Q1 2016 and within the financial outlook provided on Jan. 19, 2016; hence FY 2016 outlook remains unchanged.Says ‍announces formation of three divisions: Household Care & Technical Industries, Agriculture & Bioenergy and Food & Beverages​.Says expects that total costs associated with the reorganization will be 60-70 million Danish crowns.  Full Article

Novozymes launches probiotic for poultry‍​
Monday, 25 Jan 2016 04:01am EST 

Novozymes A/S:Says it and Adisseo 600299.SS have launched their first probiotic for poultry on the U.S. market and in a number of countries in the Middle East and South East Asia.Says the product optimizes feed conversion by 2 to 2.5 percent, meaning less feed consumed to raise an animal.Says estimates the probiotics market at 200-300 million euros ($217-325 million) and 8-10 percent annual growth.The partners strive to become key players in probiotics for animals and accelerate the expansion of the market.  Full Article

Novozymes : BioAg Alliance targets 25-50 percent of all US farmland by 2025-Reuters
Wednesday, 18 Nov 2015 01:14am EST 

Novozymes A/S:Says Monsanto and Novozymes, the BioAg Alliance, targets 250-500 million acres by 2025, equivalent to 25-50 percent of all U.S. farmland-Reuters.As per Nov. 18, the Alliance's products are used on around 65 million acres.  Full Article

More From Around the Web